DRUG · Mapped RxNorm record
celecoxib
Normalized identity: celecoxibView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women
NCT00088972
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedS0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Interventions
celecoxibDRUG · verified · RxNorm: celecoxib
placeboOTHER
Sponsors & collaborators
SWOG Cancer Research Networklead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00088972 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.